High-Performance Liquid Chromatography for Analyses of Antibiotics in Biological Fluids
- 1 August 1983
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 6 (sup002) , 251-293
- https://doi.org/10.1080/01483918308062876
Abstract
The discovery of penicillin and subsequently other antibiotics represents one of the great progresses in modern medicine. Newer agents, such as the aminoglyco-sides and the cephalosporins, have also contributed significantly to man's struggle against bacterial and fungal infections, and antiviral agents are expected to emerge in the next decades. The evergrowing number of antibiotics have, however, also given rise to several problems. The emergence of bacterial strains resistant to antibiotics is a matter of increasing concern to the medical profession and necessitates the continuing search for new antimicrobial agents and judicious therapy with the ones already in use. Many antibiotics exert undesired toxic side effects when given in excessive doses: examples are the oto-and nephrotoxicity of aminoglycosides, the bone-marrow depressant action of chloramphenicol and the nephrotoxic effects of some of the early cephalosporins. Even a comparatively nontoxic drug such as penicillin causes coma and convulsions at high levels in the cerebrospinal fluid. To avoid such undesired effects it is of vital importance to the clinician to have a clear understanding of the pharmacological behaviour of an antibiotic. Usually, abundant data are available on the pharmacokinetics of these drugs in healthy, young volunteers but these do not represent the clinically difficult cases: the sick, often older, patient many times suffering from reduced renal or hepatic function and the very small child with immature function of liver and kidneys. When treating these patients, the clinician must be able to monitor serum levels of antibiotics to ensure safe and effective theratherapy. Therefore, when a new drug is introduced, it is necessary to perform extensive investigations of pharmacokinetic behaviour not only in healthy volunteers but also in patients with and without disturbances of metabolic pathways and elimination processes in order to make adequate dosage recommendations.Keywords
This publication has 91 references indexed in Scilit:
- Determination of the cephalosporin Ro 13‐99041 in plasma, urine, and bile by means of ion‐pair reversed phase chromatographyJournal of High Resolution Chromatography, 1981
- Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and childrenThe Journal of Pediatrics, 1981
- Plasma Protein Binding and Urinary Excretion of R- and S-Epimers of an Arylmalonylamino 1-Oxacephem I: In HumansJournal of Pharmaceutical Sciences, 1981
- Doxycycline Determination in Human Serum and Urine by High-Performance Liquid ChromatographyJournal of Pharmaceutical Sciences, 1979
- Pharmacokinetics of Cephalothin: Accumulation of Its Deacetylated Metabolite in Uremic PatientsThe Journal of Infectious Diseases, 1979
- Rapid and Micro High-pressure Liquid Chromatographic Determination of Chloramphenicol in PlasmaJournal of Pharmaceutical Sciences, 1978
- Pharmacokinetics of cefamandole using a HPLC assayJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Determination of chloramphenicol in serum and cerebrospinal fluid with high-pressure liquid chromatographyJournal of Antimicrobial Chemotherapy, 1978
- Quantitation of the Antimalarial Agent, Mefloquine, in Blood, Plasma, and Urine Using High-Pressure Liquid ChromatographyJournal of Pharmaceutical Sciences, 1977
- Improved fluorometric determination of tetracyclinesBiochemical Medicine, 1972